These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 9796958)

  • 1. Response of MCF7 human breast cancer to tamoxifen: evaluation by the three-time-point, contrast-enhanced magnetic resonance imaging method.
    Furman-Haran E; Grobgeld D; Margalit R; Degani H
    Clin Cancer Res; 1998 Oct; 4(10):2299-304. PubMed ID: 9796958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal regulation of VEGF in orthotopic MCF7 human breast cancer.
    Bogin L; Degani H
    Cancer Res; 2002 Apr; 62(7):1948-51. PubMed ID: 11929808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen enhances cell death in implanted MCF7 breast cancer by inhibiting endothelium growth.
    Haran EF; Maretzek AF; Goldberg I; Horowitz A; Degani H
    Cancer Res; 1994 Nov; 54(21):5511-4. PubMed ID: 7923186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging measurements of vascular permeability and extracellular volume fraction of breast tumors by dynamic Gd-DTPA-enhanced relaxometry.
    Vincensini D; Dedieu V; Eliat PA; Vincent C; Bailly C; de Certaines J; Joffre F
    Magn Reson Imaging; 2007 Apr; 25(3):293-302. PubMed ID: 17371717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
    Wilmes LJ; Pallavicini MG; Fleming LM; Gibbs J; Wang D; Li KL; Partridge SC; Henry RG; Shalinsky DR; Hu-Lowe D; Park JW; McShane TM; Lu Y; Brasch RC; Hylton NM
    Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of angiogenesis adds information to estrogen receptor status in predicting the efficacy of adjuvant tamoxifen in node-positive breast cancer patients.
    Gasparini G; Fox SB; Verderio P; Bonoldi E; Bevilacqua P; Boracchi P; Dante S; Marubini E; Harris AL
    Clin Cancer Res; 1996 Jul; 2(7):1191-8. PubMed ID: 9816287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parametric imaging of tumor perfusion using flow- and permeability-limited tracers.
    Bogin L; Margalit R; Mispelter J; Degani H
    J Magn Reson Imaging; 2002 Sep; 16(3):289-99. PubMed ID: 12205585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging of breast cancer angiogenesis: a review.
    Furman-Haran E; Kelcz F; Degani H
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):47-54. PubMed ID: 12585654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parametric imaging of tumor perfusion with deuterium magnetic resonance imaging.
    Bogin L; Margalit R; Ristau H; Mispelter J; Degani H
    Microvasc Res; 2002 Jul; 64(1):104-15. PubMed ID: 12074636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR appearance of endometrial carcinoma and mucinous cystadenoma in a postmenopausal patient treated with tamoxifen for breast cancer.
    Joja I; Asakawa T; Ando Y; Shiraiwa M; Shibutani O; Akaki S; Kuroda M; Mizutani Y; Kudo T; Hiraki Y
    Radiat Med; 1998; 16(4):315-9. PubMed ID: 9814431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic contrast-enhanced magnetic resonance imaging reveals stress-induced angiogenesis in MCF7 human breast tumors.
    Furman-Haran E; Margalit R; Grobgeld D; Degani H
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6247-51. PubMed ID: 8692800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor microvascular changes in antiangiogenic treatment: assessment by magnetic resonance contrast media of different molecular weights.
    Turetschek K; Preda A; Novikov V; Brasch RC; Weinmann HJ; Wunderbaldinger P; Roberts TP
    J Magn Reson Imaging; 2004 Jul; 20(1):138-44. PubMed ID: 15221819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiestrogenic effect of 20S-protopanaxadiol and its synergy with tamoxifen on breast cancer cells.
    Yu Y; Zhou Q; Hang Y; Bu X; Jia W
    Cancer; 2007 Jun; 109(11):2374-82. PubMed ID: 17464948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring breast cancer response to neoadjuvant systemic chemotherapy using parametric contrast-enhanced MRI: a pilot study.
    Chou CP; Wu MT; Chang HT; Lo YS; Pan HB; Degani H; Furman-Haran E
    Acad Radiol; 2007 May; 14(5):561-73. PubMed ID: 17434070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Response evaluation with functional magnetic resonance mammography].
    Knopp M
    Zentralbl Gynakol; 1996; 118(10):571-2. PubMed ID: 8999711
    [No Abstract]   [Full Text] [Related]  

  • 16. A pilot study to establish a clinical model to perform phase II studies of breast cancer chemopreventive agents in women at high risk with biomarkers as surrogate endpoints for activity.
    Stearns V; Gallagher A; Kleer CG; Singh B; Freedman M; Haddad BR; Isaacs C; Warren R; Brown M; Cullen J; Trock B; Hayes DF
    Clin Cancer Res; 2004 Dec; 10(24):8332-40. PubMed ID: 15623610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen inhibits secretion of vascular endothelial growth factor in breast cancer in vivo.
    Garvin S; Dabrosin C
    Cancer Res; 2003 Dec; 63(24):8742-8. PubMed ID: 14695189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative measurement of epidermal growth factor receptor is a negative predictive factor for tamoxifen response in hormone receptor positive premenopausal breast cancer.
    Giltnane JM; Rydén L; Cregger M; Bendahl PO; Jirström K; Rimm DL
    J Clin Oncol; 2007 Jul; 25(21):3007-14. PubMed ID: 17634479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease in tumor apparent permeability-surface area product to a MRI macromolecular contrast medium following angiogenesis inhibition with correlations to cytotoxic drug accumulation.
    Daldrup-Link HE; Okuhata Y; Wolfe A; Srivastav S; Øie S; Ferrara N; Cohen RL; Shames DM; Brasch RC
    Microcirculation; 2004; 11(5):387-96. PubMed ID: 15280064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raloxifene and breast cancer.
    Lorraine J
    CMAJ; 2001 Oct; 165(7):888. PubMed ID: 11599326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.